Formulation and in vitro evaluation of nifedipine-controlled release tablet: Influence of combination of hydrophylic and hydrophobic matrix forms

Asian Journal of Pharmaceutics

Volumn 4, Issue 4, 2010, Pages 185-193

  Derakhshandeh, Katayoun ^a   Soleymani, Marzieh ^a  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Controlled release; matrix tablet; nifedipine; release kinetics

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; NIFEDIPINE; SODIUM DIHYDROGEN PHOSPHATE;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG GRANULATION; DRUG SCREENING; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MATRIX TABLET; SUSTAINED DRUG RELEASE; TABLET FRIABILITY; TABLET HARDNESS; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 79951972362     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.76739     Document Type: Article

References (32)

1. Apu AS, Pathan AH, Shrestha D, Kibria G, Jalil R. Investigation of In vitro Release Kinetics of Carbamazepine from Eudragit® RS PO and RL PO Matrix Tablets. Trop J Pharm Res 2009;8:145-52.
2. gastrointestinal therapeutic system (GITS), evaluation of pharmaceutical, pharmacokinetic and pharmacological properties. Clin Pharmacokin 1996;30:28-51.
3. Eur J Pharmacol 1996;50:195-201.
4. as a major determinant of its haemodynamic effects in humans. Clin Pharmacol Ther 1987;41:26-30.
5. th ed. Montvale, NJ: Medical Economics Company Inc; 2000. p. 331: 2363.
6. Kohri N, Mori KI, Miyazaki K, Arita T. Sustained release of nifedipine from granules. J Pharm Sci 1986;75:57-61. (Pubitemid 16160544)
7. Barkai A, Pathak YV, Benita S. Polyacrylate (Eudragit retard) microspheres for oral controlled release of nifedipine. Drug Dev Ind Pharm 1990;16:2057-75.
8. Chowdary KR, Ramesh KS. Controlled nifedipine release from microcapsules of its dispersions in PVP-MCC and HPC-MCC. Drug Dev Ind Pharm 1995;21:1183-92.
9. Maggi L, Torre ML, Giunchedi P, Conte U. Supramicellar solutions of sodium dodecyl sulphate as dissolution media to study in vitro release characteristics of sustained release formulations containing an insoluble drug: Nifedipine. Int J Pharm 1996;135:73-9. (Pubitemid 26260875)
10. Mehrgan H, Mortazavi SA. The release behavior and kinetic evaluation of diltiazem HCL from various hydrophilic and plastic based matrices. Iran. J Pharm Res 2005;3:137-46.
11. Colombo P. Swelling-controlled release in hydrogel matrices for oral route. Adv Drug Deliv Rev 1993;11:37-57. (Pubitemid 23257482)
12. Bravo SA, Lamas MC, Salomon CJ. Swellable matrices for the controlled-release of diclofenac sodium: Formulation and in-vitro studies. Pharm Dev Technol 2004;9:75-83 (Pubitemid 38250228)
13. Reza MS, Quadir MA, Haider SS. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery. J Pharm Pharmaceut Sci 2003;6:282-91. (Pubitemid 37207234)
14. Rowe RC. Molecular weight dependence of the properties of ethyl cellulose and hydroxypropyl methylcellulose films. Int J Pharm 1992;88:405-8. (Pubitemid 23000444)
15. Akbuga J. Furosemide-loaded ethyl cellulose microspheres prepared by spherical crystallization technique: Morphology and release characterization. Int J Pharm 1991;76:193-8.
16. Janselijak I, Nicolaidou CF, Nixon JR. Dissolution from tablets prepared using ethylcellulose microcapsules. J Pharm Pharmacol 1977;29:169-72. (Pubitemid 8040867)
17. Shaikh NA, Abidi SE, Block LH. Evaluation of ethyl cellulose as a matrix for prolonged release formulations. Part 1. Water-soluble drugsacetaminophen theophylline. Drug Dev Ind Pharm 1987;13:1345-69.
18. Kibbe AH. Handbook of pharmaceutical excipients. Washington, D.C.: USA, American Pharmaceutical Association; 2000. p. 401-6.
19. Garg R. Pre-formulation: A need for dosage form design. Pharmainfo Net 2008. vol.6.
20. Banker G, Rhodes CT. Modern Pharmaceutics. New York: Marcel Dekker, Inc.; 2000.
21. Pharmacopoeia of India. Ministry of health and family welfare. New Delhi: Government of India controller of publications; 2007. p. 663,183, 662.
22. Najib N, Suleiman M. The kinetics of drug release from ethyl cellulose solid dispersions. Drug Dev Ind Pharm 1985;11:2169-81. (Pubitemid 16207535)
23. Desai SJ, Singh P, Simonelli AP, Higuchi WI. Investigation of factors influencing release of solid drug dispersed in wax matrices III. Quantitative studies involving polyethylene plastic matrix. J Pharm Sci 1966;55:1230-4.
24. Higuchi T. Mechanism of sustained action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145-9.
25. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35. (Pubitemid 13092121)
26. Banker GS, Anderson LR. Tablets. In: Lachman L, Liberman HA, Kanig JL, editors, The theory and practice of industrial pharmacy. Mumbai, India: Varghese Publishing House; 1987. p. 293-345.
27. Akubuga J. Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization. Int J Pharm 1989;53:99-105.
28. Patra C, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm 2007;57:479-89.
29. Kuksal A, Tiwary AK, Jain N, Jain S. Formulation and In vitro, In vivo evaluation of extended- release matrix tablet of zidovudine: Influence of combination of hydrophilic and hydrophobic matrix formers. AAPS PharmSci Tech 2006;7:E1.
30. Khandai M, Chakraborty S, Sharma A, Panda D, Khanam N, Panda SK. Development of propranolol hydrochloride matrix tablets: An investigation of effects of combination of hydrophilic and hydrophobic matrix forms using multiple comparison analysis. Int J Pharm Sci 2010;1:1-7.
31. Rajabi-Siabhoomi AR, Melia CD, Davies MC, Bowtell RW, Mcjury M, Sharp JC. Imaging the internal structure of the gel layer in hydrophilic matrix systems by NMR microscopy. J Pharm Pharmacol 1992;44:1062.
32. Sarfraz M, Rehamn NU, Mohsin S. Naproxen release from sustained release matrix system and effect of cellulose derivations. Pak J Pharm Sci 2006;19:251-5.